11.5 C
London
Saturday, February 22, 2025
HomeMarketsEurope Markets

Europe Markets

spot_img

Memantine Mylan | European Medicines Agency (EMA)

OverviewThis is a summary of the European public assessment report (EPAR) for Memantine Mylan. It explains how the Agency assessed the medicine to...

Sapropterin Dipharma | European Medicines Agency (EMA)

OverviewSapropterin Dipharma is a medicine that is used to treat high blood levels of phenylalanine in adults and children of all ages with...

Saxenda | European Medicines Agency (EMA)

OverviewSaxenda is a medicine used along with diet and increased physical activity to help manage weight in:adults who have obesity (BMI of 30...

Tuznue | European Medicines Agency (EMA)

OverviewTuznue is a cancer medicine used to treat the following conditions:early breast cancer (when the cancer has spread within the breast or to...

Frequently asked questions | European Medicines Agency (EMA)

A general 'Site-wide search' bar is featured at the top right of every page on the EMA website. It allows you to perform...

Fabhalta | European Medicines Agency (EMA)

OverviewFabhalta is a medicine used in adults with paroxysmal nocturnal haemoglobinuria (PNH) to treat haemolytic anaemia.PNH is a disease in which the excessive...

Qaialdo | European Medicines Agency (EMA)

OverviewQaialdo is a medicine used to manage refractory oedema (swelling due to fluid build-up that does not respond to standard treatments) associated with...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

spot_img